Covered recipient · General Payments record
MICHAEL J PATTILLO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,926.42
- Reported across 335 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $633.92 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $309.13 | 17 |
| SANOFI PASTEUR INC. | $48.62 | 1 |
| Exact Sciences Corporation | $42.06 | 2 |
| Novo Nordisk AS | $35.64 | 2 |
| Lilly USA, LLC | $32.33 | 2 |
| Acerta Pharma LLC | $30.46 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.36 | 1 |
| Astellas Pharma US Inc | $26.10 | 1 |
| Amgen Inc. | $25.56 | 1 |
| Lundbeck LLC | $22.71 | 1 |
| GlaxoSmithKline, LLC. | $16.83 | 1 |
| PFIZER INC. | $16.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.12 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212900 | CMS |
| ABBVIE INC. | $20.65 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212904 | CMS |
| ABBVIE INC. | $22.30 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212908 | CMS |
| ABBVIE INC. | $26.61 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212912 | CMS |
| ABBVIE INC. | $22.23 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212916 | CMS |
| ABBVIE INC. | $24.01 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212920 | CMS |
| ABBVIE INC. | $16.00 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212924 | CMS |
| ABBVIE INC. | $26.03 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212928 | CMS |
| ABBVIE INC. | $12.23 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212932 | CMS |
| ABBVIE INC. | $6.03 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212936 | CMS |
| ABBVIE INC. | $24.03 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212940 | CMS |
| ABBVIE INC. | $6.14 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212944 | CMS |
| ABBVIE INC. | $17.53 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212949 | CMS |
| ABBVIE INC. | $11.14 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212953 | CMS |
| ABBVIE INC. | $12.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212957 | CMS |
| ABBVIE INC. | $3.25 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212961 | CMS |
| ABBVIE INC. | $26.26 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212965 | CMS |
| Amgen Inc. | $25.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117349702 | CMS |
| Astellas Pharma US Inc | $26.10 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139305356 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.20 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104264099 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.26 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105526601 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.36 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118266373 | CMS |
| Exact Sciences Corporation | $16.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114828549 | CMS |
| Exact Sciences Corporation | $25.59 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114828555 | CMS |
| GlaxoSmithKline, LLC. | $16.83 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116004876 | CMS |
| Lilly USA, LLC | $15.48 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135194304 | CMS |
| Lilly USA, LLC | $16.85 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135217401 | CMS |
| Lundbeck LLC | $22.71 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145955103 | CMS |
| Novo Nordisk Inc | $13.33 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014235 | CMS |
| Novo Nordisk Inc | $22.31 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097831722 | CMS |
| PFIZER INC. | $16.12 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132009122 | CMS |
| SANOFI PASTEUR INC. | $48.62 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128739392 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.